Illumina Non Current Liabilities Other from 2010 to 2024
| ILMN Stock | USD 136.99 5.31 4.03% |
Non Current Liabilities Other | First Reported 2010-06-30 | Previous Quarter 642 M | Current Value 331 M | Quarterly Volatility 243.8 M |
Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 453.6 M, Interest Expense of 60.3 M or Total Revenue of 4.7 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0 or PTB Ratio of 5.32. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.
Illumina | Non Current Liabilities Other |
Latest Illumina's Non Current Liabilities Other Growth Pattern
Below is the plot of the Non Current Liabilities Other of Illumina over the last few years. It is Illumina's Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Other | 10 Years Trend |
|
Non Current Liabilities Other |
| Timeline |
Illumina Non Current Liabilities Other Regression Statistics
| Arithmetic Mean | 317,644,659 | |
| Geometric Mean | 235,177,891 | |
| Coefficient Of Variation | 76.17 | |
| Mean Deviation | 180,634,924 | |
| Median | 213,955,000 | |
| Standard Deviation | 241,958,693 | |
| Sample Variance | 58544T | |
| Range | 886.5M | |
| R-Value | 0.77 | |
| Mean Square Error | 25903.2T | |
| R-Squared | 0.59 | |
| Significance | 0.0008 | |
| Slope | 41,527,711 | |
| Total Sum of Squares | 819616.1T |
Illumina Non Current Liabilities Other History
About Illumina Financial Statements
Illumina investors utilize fundamental indicators, such as Non Current Liabilities Other, to predict how Illumina Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Other | 620 M | 357.6 M |
Pair Trading with Illumina
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.Moving against Illumina Stock
| 0.69 | VCNX | Vaccinex | PairCorr |
| 0.58 | DTIL | Precision BioSciences | PairCorr |
| 0.53 | VALN | Valneva SE ADR Downward Rally | PairCorr |
| 0.52 | ME | 23Andme Holding | PairCorr |
| 0.51 | DRMA | Dermata Therapeutics | PairCorr |
The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.
The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Illumina Correlation against competitors. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share (9.98) | Revenue Per Share 27.654 | Quarterly Revenue Growth (0.04) | Return On Assets 0.0262 |
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.